Based on the toxicity of the AGE-RAGE system in cardiovascular disorders, AGE-RAGE-targeted therapeutic approaches are extensively studied, and the application of sRAGE is considered as one of the most suitable targets due to that it possesses natural features of the RAGE antagonist and due to promising results in AGE-RAGE-induced disorders. Here, RENBP is linked to cardiovascular disorder.